US Must Reshore AI Drug Discovery Infrastructure | Kevin Weil artwork

US Must Reshore AI Drug Discovery Infrastructure | Kevin Weil

MTS

October 23, 2026

Warp Sciences co-founder and CEO Kevin Weil discusses emerging from stealth with $215 million to build AI-driven, automated chemistry labs in the US.

0:00

Kevin Weil

The thing that people don't know is that whole three to five years of making and testing molecules, we've outsourced it entirely to China.

So it all happens in China, and it's really dangerous, right? So there's this amazing quote from Andy Grove, who used to run Intel, when he was talking about semiconductors and the same thing happening there. And he said, abandoning today's commodity manufacturing can lock you out of tomorrow's emerging industry. That is the path that we are on with Pharma. It's really dangerous, but it's not too late to take it back. And that's why we care so much about bringing this back to the US.

0:38

SPEAKER_2

Hello, everyone. Welcome back to MTS. Today, I am joined live with Kevin Weil, the co-founder and CEO of Warp Sciences, which emerged from stealth today with $215 million to bring AI into the lab and build US chemistry services for drug research. Kevin, super excited to talk to you. Welcome to MTS.

0:59

Kevin Weil

Thank you for having me.

1:01

SPEAKER_2

Thank you for joining. I know you guys are fresh off the launch announcement. You announced it earlier this morning. Tell me a little bit about what was actually announced. Why now?

Yeah.

1:10

Kevin Weil

So at Warp, we're using AI and robotics to help the world discover medicines faster. So we're building robotic labs that do science at scale, and we're doing it here in America.

There's like, there's two big pieces to this. One is, I think robotic labs are going to be one of the best ways that we have to accelerate science across the board, right?

Partly because you can just run more experiments when you have labs operating 24-7, but also because doing this kind of science at scale is the way that we're going to generate training data, which the models desperately need to become better at the kind of core science, like chemistry, biology, drug discovery. The other thing, and a lot of people don't know this, we need to reshore scientific capabilities from China so that we don't lose our pharma industry, the way that we lost solar and drones and manufacturing. And so for us, there is one solution to both of these, which is we are building a next generation preclinical CRO. That's a contract research organization, starting with small molecule chemistry, and it's built here in America. So we're not developing drugs on our own. We are building the infrastructure so that everybody who does develop drugs can go faster.

2:23

SPEAKER_2

Yeah, this is particularly interesting around the reshoring piece. I think this is a key area that most people don't totally realize.

What exactly is happening right now? Like, why is this a concern that we're not doing it fully here in the States?

2:37

Kevin Weil

Yeah, so maybe I'll step back and give just kind of an overview of the drug discovery process. I think it's helpful context. So imagine you and I start a drug discovery company, like you're coming off of your PhD in biology and you've been studying some form of cancer.

And usually you have a biological hypothesis. You say, okay, there's some protein, and maybe it like overexpresses and we need to inhibit it. And we would start this biotech with a hypothesis that if we could inhibit this protein with a drug, then we have a positive effect on people's cancer. So we would find a molecule that bound to the protein.

But most likely that first molecule that you find is gonna be toxic or it's gonna not be soluble or it's not gonna be very potent. So instead of being able to take a little pill of it, you have to take a kilogram of it, which makes it not viable as a drug. And so the next step that we would go through is we would spend the next three to five years making variations of this molecule, hoping that we could find one that was less toxic, more potent, more soluble, more selective, et cetera. So you go through this big long process. And once you find that one, then you go into clinical trials and all that, right? So this is the drug making process. But the thing that people don't know is that whole three to five years of making and testing molecules, we've outsourced it entirely to China.

4:07

SPEAKER_2

Wow.

4:07

Kevin Weil

So it all happens in China and it's really dangerous, right?

This is a core part of the process of turning an idea into a new medicine. And we cannot depend on what is a geopolitical adversary to do this work for us.

4:26

SPEAKER_2

I want to shout out our sponsor, Lovable. You know the app you've been meaning to build? The internal tool, side project, or product you'd otherwise lose a weekend to? With Lovable, you get software you can ship today. That includes an editable code base you can inspect and change plus two-way GitHub sync. Lovable also handles the backend and infrastructure, including managed Postgres, auth, storage, hosting, payments, and more. So you don't have to wire it all up yourself.

Read the other 12 minutes of this episode here.

$15 gets you this episode and 99 more. Credits never expire. After checkout, one link brings you back here to read it.

Not what you expected? Full refund within 14 days.

Thousands of transcripts fetched by people building searchable podcast archives

Fetch transcripts with code

The same credits work from a script or an AI agent. The demo key returns a sample episode in full, no card needed:

request
curl -H "x-api-key: pt_demo" \
  https://spoken.md/transcripts/1000651996090

Markdown with the speakers named, for your notes, your knowledge base, or anything that makes HTTP calls.

From $0.10 per transcript. No subscription. Credits never expire. Prices exclude VAT, added at checkout for EU customers. Not what you expected? Email us within 14 days with 20 or fewer credits used and we refund the pack in full.

Using your own key:

request
curl -H "x-api-key: YOUR_KEY" \
  https://spoken.md/transcripts/1000797718076